Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [237]

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend and enhance treatment responses

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend...

ASH 2018: Two studies suggest luspatercept reduces need for blood transfusions

ASH 2018: Two studies suggest luspatercept reduces need for blood transfusions

Small populations of normal cells affect immunity in patients with XLP1

Small populations of normal cells affect immunity in patients with XLP1

Study shows potential to develop brain tumour liquid biopsies

Study shows potential to develop brain tumour liquid biopsies

Mount Sinai develops nanotechnology-based immunotherapy promoting transplant acceptance

Mount Sinai develops nanotechnology-based immunotherapy promoting transplant acceptance

First of its kind research models immune responses in cellular immunotherapies

First of its kind research models immune responses in cellular immunotherapies

Relapsed leukaemia flies under immune system's radar

Relapsed leukaemia flies under immune system's radar

Latest Cornell dot features a new cancer weapon: Antibodies

Latest Cornell dot features a new cancer weapon: Antibodies

Killer cell immunotherapy offers potential cure for advanced pancreatic cancer

Killer cell immunotherapy offers potential cure for advanced pancreatic cancer

Researchers uncover a tumour cell population responsible for resistance to therapy and tumour relapse

Researchers uncover a tumour cell population responsible for resistance to therapy and tumour relapse

More from ecancer